Table 3.
Erdafitinib treatment outcomes.
| Type of response | Value n (%) |
|---|---|
| Best overall response | |
| Complete response | 3 (12%) |
| Partial response | 8 (32%) |
| Stable disease | 3 (12%) |
| Progressive disease | 11 (44%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.